Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for esr1 protein, human (compound)
Most Correlated Studies
- Breast cancer MCF7 cells overexpressing ROR2 with or without stimulation by its ligand WNT5A
- Embryonic stem cell lines expressing hormone-dependent STAT3-ERT2 treated with LIF and 2i inhibitors
- Chronic myelogenous leukemia cells engineered to express CEBPa-ER fusion protein
- Breast tumors with pathologic complete response (pCR) or residual disease (RD) upon chemotherapy
- Response of breast tumors treated with docetaxel-capecitabine (+/- trastuzumab)
Most Relevant Literature
- Reduced camptothecin sensitivity of estrogen receptor-positive human breast cancer cells following e…
- A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women…
- Microdeletion at ESR1 Intron 6 (DEL_6_75504) Is a Susceptibility Factor for Cryptorchidism and Hypos…
- Capivasertib-Induced Diabetic Ketoacidosis in a Patient With Estrogen Receptor-Positive/Human Epider…
- ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex …
Most Relevant Clinical Trials
- Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Es…
- Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Po…
- Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Br…
- Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Ar…
- Abemaciclib and Letrozole to Treat Endometrial Cancer
